Publication | Closed Access

Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: A double-blind, placebo-controlled trial

Psychoactive DrugPsychiatryPsychotic DisorderPsychotropic MedicationPharmacologyPsychopharmacologySchizophreniaNeuropharmacologyNeuropsychiatryWeight GainPharmacotherapyPlacebo-controlled TrialMetabolic DysfunctionSocial SciencesMedicinePsychopathology